CYP450 inhibition (7 isoform) assay data sheet

Inhibitory potency (IC50) provides invaluable information regarding drug interaction potential. The IC50 of test compound against the seven FDA-recommended CYP450 metabolizing enzymes is determined using specific drug probe substrates. Analysis is by LC-MSMS.

Deliverable: IC50 (μM) of test compound against CYP1A2, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6 & CYP3A4 (Midazolam & Testosterone).

Please fill in this form to access the full resource

You may also be interested in.

Application of a GLP protocol for the measurement of 17β-estradiol and testosterone by LC-MS/MS in the H295R steroidogenesis assay, Test No 456
Jun 5, 2023
English
Poster

Application of a GLP protocol for the measurement of 17β-estradiol and testosterone by LC-MS/MS in the H295R steroidogenesis assay, Test No 456

Find out more
In-Vitro Assay Modelling For Potential Cancer Immunotherapies
May 25, 2023
English
Webinar

In-Vitro Assay Modelling For Potential Cancer Immunotherapies

Find out more
Opportunities & challenges in mRNA LNP discovery for immunotherapy
May 25, 2023
English
Webinar

Opportunities & challenges in mRNA LNP discovery for immunotherapy

Find out more